PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·
← Leaderboard
AMED
Ticker

AMED

Congressional Trades
4
by 1 members
Buys
2
50%
Sells
2
50%
Total Volume
$32K
midpoint
Unique Traders
1
members

Party Breakdown

Democrats0 · 0%
Republicans4 · 100%

Party Trading Divergence

Democrat vs. Republican buy / sell pressure by monthALIGNED

Bar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.

Democrat ←
Month
→ Republican
Jun '25
2
Aug '25
02
Democrats00Neutral
vs
Republicans22Neutral
Net buyingNet selling⚡ Party split

💼 Lobbying Filings

all →
  • 2026-04-20$30K
    AMEDISYS INC.
    Strategic guidance and counsel on home health reimbursement and policy including The Preserving Access to Home Health Act (S. 4605/ H.R. 8581)
  • 2026-01-20$30K
    AMEDISYS INC.
    Strategic guidance and counsel on home health reimbursement and policy including The Preserving Access to Home Health Act (S. 4605/ H.R. 8581)
  • 2025-10-20$30K
    AMEDISYS INC.
    Strategic guidance and counsel on home health reimbursement and policy including The Preserving Access to Home Health Act (S. 4605/ H.R. 8581)
  • 2025-07-21$30K
    AMEDISYS INC.
    Strategic guidance and counsel on home health reimbursement and policy including The Preserving Access to Home Health Act (S. 4605/ H.R. 8581)
  • 2025-04-21$410K
    AMEDISYS INC.
    Issues related to home health and hospice payment policies and funding, program integrity matters and quality metrics, continuation of hospital-at-home; Issues related to healthcare workforce matters
  • 2025-04-21$90K
    AMEDISYS INC.
    Strategic guidance and counsel on home health reimbursement and policy including The Preserving Access to Home Health Act of 2022 (S. 4605/ H.R. 8581)
  • 2025-03-31$50K
    AMEDISYS HOME HEALTH AND HOSPICE CARE
  • 2025-01-21$80K
    AMEDISYS HOME HEALTH AND HOSPICE CARE
    Payment issues related to Medicare Home Health benefit; S. 2137/H.R. 5159, Preserving Access to Home Health Act; CMS-1803-P, or the CY 2025 Home Health Prospective Payment System Rate Update; H.R. 9803, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act; H.R. 10545, American Relief Act, 2025
  • 2025-01-20$120K
    AMEDISYS INC.
    Strategic guidance and counsel on home health reimbursement and policy including The Preserving Access to Home Health Act of 2022 (S. 4605/ H.R. 8581)

Congressional Momentum

buy vs. sell pressureNEUTRAL

Score 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.

Last 30 Days
No trades
Last 90 Days
No trades
All-Time
50
2 buys4 total2 sells
$16K buys · $16K sells
Cumulative Net Position (buy vol − sell vol)
+$0
2025-064 trades plotted2025-08

Trade Activity Timeline

Congressional buys & sells by month · last 2 months w/ activity

25/06
25/08
BuysSellsOtherHigh-volume month

All Disclosed Trades

DateMemberActionAmountFiling Delay
2025-08-18RLisa McClainSELL$1K – $15K28d
2025-08-18RLisa McClainSELL$1K – $15K25d
2025-06-09RLisa McClainBUY$1K – $15K66d
2025-06-09RLisa McClainBUY$1K – $15K65d